This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
U4W0 Overzicht aandelen
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 0/6 |
| Dividenden | 0/6 |
Beloningen
Risicoanalyse
+ 2 meer risico's
Quotient Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | €0.12 |
| 52 Week Hoogtepunt | €15.36 |
| 52 Week Laag | €0.018 |
| Bèta | 1.36 |
| 11 maand verandering | 313.79% |
| 3 maanden verandering | 196.30% |
| 1 Jaar Verandering | -99.22% |
| 33 jaar verandering | -99.96% |
| 5 jaar verandering | -99.96% |
| Verandering sinds IPO | -99.92% |
Recent nieuws en updates
Recent updates
Rendement voor aandeelhouders
| U4W0 | DE Medical Equipment | DE Markt | |
|---|---|---|---|
| 7D | 0% | -0.6% | 1.1% |
| 1Y | -99.2% | 10.5% | 18.9% |
Rendement versus industrie: U4W0 underperformed the German Medical Equipment industry which returned 9.3% over the past year.
Rendement versus markt: U4W0 underperformed the German Market which returned 1.9% over the past year.
Prijsvolatiliteit
| U4W0 volatility | |
|---|---|
| U4W0 Average Weekly Movement | 95.4% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stabiele aandelenkoers: U4W0's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: U4W0's weekly volatility has increased from 63% to 95% over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2007 | 432 | Manuel Mendez | www.quotientbd.com |
Quotient Limited Samenvatting
| U4W0 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | €2.53m |
| Inkomsten(TTM) | -€112.90m |
| Inkomsten(TTM) | €34.05m |
0.1x
P/S-verhouding0.0x
Koers/WinstverhoudingIs U4W0 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| U4W0 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$37.41m |
| Kosten van inkomsten | US$37.13m |
| Brutowinst | US$279.00k |
| Overige uitgaven | US$124.31m |
| Inkomsten | -US$124.03m |
Laatst gerapporteerde inkomsten
Dec 31, 2022
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -5.89 |
| Brutomarge | 0.75% |
| Nettowinstmarge | -331.54% |
| Schuld/Eigen Vermogen Verhouding | -126.2% |
Hoe presteerde U4W0 op de lange termijn?
Bekijk historische prestaties en vergelijking